1. Trang chủ
  2. » Giáo Dục - Đào Tạo

Điều trị suy tim bằng dụng cụ vai trò của máy phá rung tự động và tái đồng bộ thất

38 145 1

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 38
Dung lượng 6,2 MB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Điều trị suy tim, bằng dụng cụ ,vai trò của máy, phá rung tự động, và tái đồng bộ thất

Trang 1

Anil Saxena Director Cardiac Pacing & Electrophysiology Fortis Escorts Heart Institute, New Delhi

Management Of Heart Failure Beyond Drugs:

Role of ICD and CRT

Trang 2

How to manage heart failure?

 Remove precipitating factor

 Correct the underlying etiology

 Drug therapy

Trang 3

Additionally…

 Salt and fluid management

 Life style change

 Optimize weight

 Exercise, Reduction of Stress

 Yoga, Meditation

Trang 4

CRT

Trang 5

ICD (Implantable Defibrillator)

Trang 6

What Is CRT?

Trang 7

PR interval 280 msec QRS width 160 msec

15-30% Patients with heart failure have conduction system disease

Heart Failure with Wide QRS

Trang 8

Wide QRS– Increased Mortality

(VEST study analysis)

Gottipaty et al JACC Feb 1999 supplement 145A

Trang 9

Ventricular Dysynchrony

Trang 10

Paradoxical movement of the septum

Trang 12

Benefits Of CRT In Heart Failure

• Improvement in Heart Failure

❖ Increased cardiac output CO (20-25%)

❖ Improved NYHA Class (approx 1)

❖ Reduced number of hospital admissions

❖ Improved quality of life

❖ Reduced mitral regurgitation

• Reduction in progression of heart failure

• Reduced mortality

Trang 13

CRT in Mild Heart Failure?

Trang 14

REVERSE Trial:

Moving towards preventive role of CRT

J Am Coll Cardiol 2008; 52:1834–43

Trang 15

REVERSE Trial:

Moving towards preventive role of CRT

J Am Coll Cardiol 2008; 52:1834–43

Trang 16

REVERSE Trial:

Moving towards preventive role of CRT

J Am Coll Cardiol 2008; 52:1834–43

Trang 17

MADIT-CRT Trial:

Moving towards preventive role of CRT

N Engl J Med 2009;361:1329-38

Trang 18

MADIT-CRT Trial:

Moving towards preventive role of CRT

N Engl J Med 2009;361:1329-38

Trang 19

MADIT-CRT Trial:

Moving towards preventive role of CRT

N Engl J Med 2009;361:1329-38

Trang 20

RAFT Trial:

Moving towards preventive role of CRT

N Engl J Med 2010;363:2385-95

Trang 21

Consensus Guidelines For CRT

Trang 22

Guidelines for CRT in Heart Failure

Arrhythmia & Electrophysiology Review 2016:5(2):80-81

Trang 23

ESC 2016 Guidelines for CRT in Heart Failure

Ponikowski et al European Heart Journal (2016) 37, 2129–2200

Trang 24

Underlying Arrhythmia of Sudden Death

Trang 25

Died one morning after a cardiac arrest

Sudden Cardiac Death

Trang 26

Sudden Cardiac Death

The Chain Of Survival

Trang 27

ICD: Placement

Trang 28

Implantable Cardioverter Defibrillator

Trang 29

CRT-P versus CRT-D

• CRT-D is often chosen on premise, that all patients fulfilling criteria

for CRT also have approved indication for ICD

• In western countries, fraction of CRT-D is 60-80% among patients receiving cardiac resynchronisation therapy

Trang 30

CRT-P versus CRT-D

• Does CRT alone improve survival by reducing mortality?

• Will addition of ICD backup to CRT further improve survival significantly?

Trang 31

Cardiac Resynchronization: Trials

All cause mortality reduction

Characteristic CONTAK CD InSync ICD MIRACLE MUSTIC

Baseline Clinical Characteristics of 4 Randomized CRT (± ICD) Trials

Pooled data from 4 trials involving a total of 1634 patients CRT was associated with a 51% reduction in death from progressive CHF relative to controls Trend toward improvement in all-cause mortality (23% improvement), which did not reach statistical significance because of the short follow-up and

small sample size CRT reduced hospitalization for CHF by 29% (n = 1497)

Investigators concluded that CRT reduces mortality from progressive HF and HF-related hospitalizations in patients with symptomatic left ventricular

dysfunction and ventricular dyssynchrony and also shows a trend toward reducing all-cause mortality

Bradley et al JAMA 2003;289:730-740

Trang 33

Care HF Trial:

All cause mortality reduction

Death or hospitalization All cause mortality

814 patients

Randomised to (Medical therapy) or (Medical therapy + CRT)

Significant reduction in all cause mortality observed with CRT

Trang 34

Care HF Trial: Extension Phase All cause mortality reduction

Follow-up 37.4 months (range 26.1–52.6 months)

40% Reduction in mortality

Trang 35

Companion Trial:

CRT vs CRT-D: Mortality Reduction

Bristow M et al N Engl J Med 2004;350:21, 2140-50

All Cause Mortality

Trang 37

ESC 2013 Guidelines for CRT-P versus CRT-D

Trang 38

Thank You

anil.saxena@hotmail.com

Ngày đăng: 05/12/2017, 00:15

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm

w